Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)
NCT00154271
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1677
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Valsartan, Valsartan HCT
Sponsor
Novartis